• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panacea Biotec Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12420.0
  • ISIN : INE922B01023
401.40 -2 (-0.43%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    393.70

  • Today’s High

    411.65

  • Open

    400.10

  • Perv Close

    403.15

  • 52W Low

    131.76

  • 52W High

    581.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,458.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    51.26

  • Debt-Equity Ratio

    -0.43

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    2,458.60

  • RONW (%)

    -4.07

  • ROCE (%)

    -3.34

Score Board

  • Equity (₹ in Cr.)

    6.13

  • BV (₹)

    51.30

  • Sales( ₹ in Cr.)

    309.85

  • NP (in Cr.)

    -15.23

  • NP Var(%)

    -535.0

  • Div%

    0.0

  • CPS (₹)

    0.80

  • EPS (₹)

    -2.50

  • Traded Value (₹ in Lakhs)

    2,454.01

  • 52 Week High

    581.90

  • 52 Week Low

    131.76

  • Price BSE

    401.0

  • Price NSE

    401.00

  • Market Capital( in Cr.)

    2,454.01

  • P/C Ratio

    485.40

  • P/E Ratio

    -161.30

  • Price Vs.BV

    -2.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 359.60 257.07 235.50 343.56 158.09 96.21
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 359.60 257.07 235.50 343.56 158.09 96.21
Other Income 24.91 34.44 12.57 20.75 30.88 321.50
Stock Adjustments -17.79 -31.15 60.95 -14.24 28.18 -17.12
Total Income 366.72 260.36 309.02 350.07 217.15 400.59
EXPENDITURE :            
Raw Materials 123.90 131.91 173.04 162.02 86.71 59.13
Power and Fuel Cost 25.33 22.43 26.51 20.78 17.58 22.72
Employee Cost 86.53 71.03 72.50 59.47 46.64 41.16
Other Manufacturing Expenses 48.20 36.31 40.76 45.75 19.05 18.47
Selling and Administration Expenses 29.99 23.41 45.82 30.87 21.56 17.38
Miscellaneous Expenses 13.71 3.45 10.51 9.97 129.41 66.89
Employee Benefit Expenses 86.53 71.03 72.50 59.47 46.64 41.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 327.65 288.54 369.13 328.85 320.94 225.75
Operating Profit 39.07 -28.20 -60.11 21.21 -103.80 174.84
Interest 13.78 10.06 7.04 7.52 5.27 104.63
Gross Profit 25.29 -38.26 -67.15 13.69 -109.07 70.21
Depreciation 21.09 24.50 26.43 26.57 26.91 33.03
Profit Before Tax 4.20 -62.76 -93.58 -12.88 -135.98 37.18
Current Tax 0.64 0.00 0.00 2.27 39.88 7.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 24.79 0.00 -0.71 -22.78 3.13
Reported Net Profit 3.55 -87.54 -93.58 -14.44 -153.07 26.57
Extraordinary Items 0.05 5.30 0.01 3.26 -31.37 302.79
Adjusted Net Profit 3.50 -92.84 -93.59 -17.70 -121.70 -276.22
Adjustment below Net Profit -0.06 -1.90 0.50 1.38 -3.03 -0.65
P & L Balance brought forward -177.40 -87.96 5.12 18.18 174.27 148.35
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -173.91 -177.40 -87.96 5.12 18.18 174.27
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.58 -14.29 -15.28 -2.36 -24.99 4.34
Earnings Per Share(Adj)-Unit Curr 0.58 -14.29 -15.28 -2.36 -22.93 3.98
Book Value 50.20 49.63 64.24 79.43 136.97 66.75
Book Value(Adj)-Unit Curr 50.20 49.63 64.24 79.43 125.66 61.24

Shareholding Pattern

  • Promoter Group

    72.48%

  • Public Share Holding

    27.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,313,454 3.78 2,313,454 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 42,080,736 68.70 42,080,736 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 44,394,190 72.48 44,394,190 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 480,624 0.78 480,624 18
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 931,299 1.52 931,299 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,411,923 2.31 1,411,923 26
2] Non Institution
Bodies Corporate 1,324,805 2.16 1,324,805 290
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 454,715 0.74 454,715 527
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,020,208 1.67 1,020,208 650
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 535,849 0.87 535,849 1
Individuals holding nominal share capital up to Rs. 1 lakh 10,593,312 17.30 10,440,091 32,675
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 176,659 0.29 176,659 12
Others 105,233 0.17 105,233 2
Sub Total 15,444,633 25.22 15,290,412 34,224
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,250,746 100.00 61,096,525 34,256

Company Background

Panacea Biotec LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Panacea Biotec Ltd
  • BSE Code : 12420.0
  • ISIN : INE922B01023

  • Incorporation Year

    1984

  • Registered Office

    Ambala-Chandigarh Highway
    , Lalru,
    Punjab-140501

  • Telephone

    91-1762-505900

  • FAX

  • Chairman

    Rajesh Jain

  • Managing Director

    Rajesh Jain

  • Company Secretary

    Vinod Goel

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr ,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Panacea Biotec Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panacea Biotec 400.65 384.51 359.60 -160.90 3.26
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10